What are the Challenges of Biomarker Driven Trials?
Despite their promise, biomarker driven trials face several challenges, including: - Complexity and Cost: Identifying and validating biomarkers can be complex and expensive. - Limited Patient Populations: Narrowing down patients based on specific biomarkers can limit the pool of eligible participants, making recruitment more difficult. - Regulatory Hurdles: Obtaining approval for new biomarkers and associated therapies can be a lengthy and stringent process.
